U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Dobutamine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 11/06/2017
»Therapeutic Categories: Cardiovascular; Pediatric; Renal

Expand all

Baxter Healthcare (Revised 07/01/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/250 mL (NDC 0338-1073-02) Product code 2B0791, 500 mg/250 mL (NDC 0338-1075-02) Product code 2B0792, 1000 mg/250 mL (NDC 0338-1077-02) Product code 2B0793 Limited supply on allocation. Recovery August Demand increase

Hospira, Inc. (Revised 08/03/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/250 mL (1 mg/mL); Flexible Container (NDC 00409-2346-32) Next Delivery: July 2022; Estimated Recovery: September 2022

Dear Customer Letter: Availability Update for Multiple Flexible Containers

Demand increase for the drug
500 mg/250 mL (2 mg/mL); Flexible Container (NDC 00409-2347-32) Next Delivery and Estimated Recovery: July 2022

Dear Customer Letter: Availability Update for Multiple Flexible Containers

Demand increase for the drug
1000 mg/250 mL (4 mg/mL); Flexible Container (NDC 00409-3724-32) Next Delivery: September 2022; Estimated Recovery: December 2022

Dear Customer Letter: Availability Update for Multiple Flexible Containers

Demand increase for the drug
250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-20) Discontinued Discontinuation of the manufacture of the drug
500 mg/40 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-54) Discontinued Discontinuation of the manufacture of the drug
250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-01) Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: February 2023 Other
250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-02) Next Delivery: August 2022; Estimated Recovery: February 2023 Other
Back to Top